Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17306ExperimentalSmall molecule
Metavert: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Glycogen synthase kinase-3 beta and Histone deacetylase
- Formula / weight
- C16H14N4O4 · 326.312 g/mol (avg)
- Also known as
- Benzamide, n-hydroxy-4-(5-((4-methoxyphenyl)amino)-1,3,4-oxadiazol-2-yl)- · N-hydroxy-4-(5-((4-methoxyphenyl)amino)-1,3,4-oxadiazol-2-yl)benzamide
- Code names
- ALB-185357
Resolves to
Compound
Structure
InChIKey
TWABKXHHSQCZPI-UHFFFAOYSA-NSMILESCOC1=CC=C(NC2=NN=C(O2)C2=CC=C(C=C2)C(=O)NO)C=C1Targets
What you can answer from here — as of July 08, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Metavert, and which of those have an active Phase 3 trial?